Cover Image
市場調查報告書

充血:全球臨床實驗檢討

Hyperemia Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 314734
出版日期 內容資訊 英文 53 Pages
訂單完成後即時交付
價格
Back to Top
充血:全球臨床實驗檢討 Hyperemia Global Clinical Trials Review, H2, 2014
出版日期: 2014年09月21日 內容資訊: 英文 53 Pages
簡介

本報告提供充血相關臨床研究最新趨勢分析,提供您疾病·治療方法概要,及G7各國的臨床實驗狀況,彙整地區、Phase、階段別進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 充血
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量

G7各國臨床實驗數量:心血管疾病臨床實驗的充血所佔比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標的成就情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

參與充血臨床實驗的主要企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Valeant Pharmaceuticals International, Inc.
    • Riemser Pharma GmbH
    • Dr. Reddy's Laboratories Limited
  • 有代表性的研究機關·醫院臨床實驗概要
    • 東京大學
    • University Hospital, Grenoble
    • Institut Curie
    • Radboud University
    • National Heart, Lung, and Blood Institute

5個有代表性的臨床實驗簡介

附錄

目錄

GlobalData's clinical trial report, "Hyperemia Global Clinical Trials Review, H2, 2014" provides data on the Hyperemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hyperemia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Hyperemia to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hyperemia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Valeant Pharmaceuticals International, Inc.
      • Clinical Trial Overview of Valeant Pharmaceuticals International, Inc.
      • Riemser Pharma GmbH
      • Clinical Trial Overview of Riemser Pharma GmbH
      • Dr. Reddy's Laboratories Limited
      • Clinical Trial Overview of Dr. Reddy's Laboratories Limited
    • Clinical Trial Overview of Top Institutes / Government
      • The University of Tokyo
      • Clinical Trial Overview of The University of Tokyo
      • University Hospital, Grenoble
      • Clinical Trial Overview of University Hospital, Grenoble
      • Institut Curie
      • Clinical Trial Overview of Institut Curie
      • Radboud University
      • Clinical Trial Overview of Radboud University
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hyperemia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Hyperemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hyperemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hyperemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Hyperemia Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Hyperemia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Hyperemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Hyperemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hyperemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Hyperemia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Hyperemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Hyperemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hyperemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hyperemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hyperemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Hyperemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hyperemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hyperemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2014*
  • Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Riemser Pharma GmbH, 2014*
  • Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2014*
  • Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2014*
  • Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Grenoble, 2014*
  • Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Curie, 2014*
  • Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2014*
  • Hyperemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*

List of Figures

  • Hyperemia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Hyperemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hyperemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hyperemia Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Proportion of Hyperemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Hyperemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hyperemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Hyperemia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Hyperemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Hyperemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hyperemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hyperemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hyperemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Hyperemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hyperemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hyperemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top